{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-21-039644","form_type":"8-K","ticker":"ELDN","cik":"0001404281","company_name":"Eledon Pharmaceuticals, Inc.","filed_at":"2021-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.967108+00:00","generated_at":"2026-06-29T23:51:15.948813+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Eledon Pharma announces resignation of Principal Accounting Officer, appoints Paul Little as successor","bullets":["Jon Kuwahara resigned as SVP, Finance & Administration and Principal Accounting Officer effective July 31, 2021.","Paul Little, current CFO and Principal Financial Officer, appointed as Principal Accounting Officer effective same date.","No family relationships or arrangements were disclosed in connection with the appointment."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-21-039644","json":"https://secwatch.observer/filing/0001564590-21-039644.json","markdown":"https://secwatch.observer/filing/0001564590-21-039644.md","text":"https://secwatch.observer/filing/0001564590-21-039644.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1404281/000156459021039644/0001564590-21-039644-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1404281/000156459021039644/eldn-8k_20210731.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T23:51:15.948813+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"25b3d473d6","claim":"Paul Little was appointed as Principal Accounting Officer at Eledon Pharmaceuticals, Inc..","evidence_excerpt":"the Company’s Board of Directors appointed Paul Little as the Company’s Principal Accounting Officer, effective as of July 31, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1404281/000156459021039644/0001564590-21-039644-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Principal Accounting Officer"}],"fact_type":"executive_change"},{"claim_id":"4df9d597a9","claim":"Jon Kuwahara resigned as Senior Vice President, Finance & Administration and Principal Accounting Officer at Eledon Pharmaceuticals, Inc..","evidence_excerpt":"Effective July 31, 2021, Jon Kuwahara resigned as the Senior Vice President, Finance & Administration and Principal Accounting Officer of Eledon Pharmaceuticals, Inc. (the “Company”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1404281/000156459021039644/0001564590-21-039644-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Senior Vice President, Finance & Administration and Principal Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}